Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 157,150 | 3,924 | N/A | N/A |
| Other current assets | 276 | 513 | 0 | 0 |
| TOTAL | $160,397 | $4,652 | $N/A | $N/A |
| Non-Current Assets | ||||
| Other Non-Current Assets | 2,486 | 40 | 0 | 0 |
| TOTAL | $2,486 | $40 | $N/A | $N/A |
| Total Assets | $162,883 | $4,692 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 2,554 | 1,252 | N/A | N/A |
| Accounts payable and accrued liabilities | 3,628 | 1,878 | 0 | 0 |
| Accrued Expenses | 3,581 | 1,173 | N/A | N/A |
| TOTAL | $9,763 | $4,303 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 1,922 | 3,193 | N/A | N/A |
| Other Non-Current Liabilities | 1,771 | 20 | 0 | 0 |
| TOTAL | $3,693 | $3,213 | $N/A | $N/A |
| Total Liabilities | $13,456 | $7,516 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 310 | N/A | N/A | N/A |
| Common Shares | 2 | 1 | N/A | N/A |
| Retained earnings | -60,841 | -31,302 | N/A | N/A |
| Other shareholders' equity | 0 | 27,813 | 0 | 0 |
| TOTAL | $149,427 | $-2,824 | $N/A | $N/A |
| Total Liabilities And Equity | $162,883 | $4,692 | $0 | $0 |